Fmoc-L-aspartic acid β-allyl ester is a protected amino acid derivative in which L-aspartic acid is functionalized at the side-chain carboxyl group as a β-allyl ester while the α-amino group is protected with an Fmoc (9-fluorenylmethoxycarbonyl) group. The molecule contains both an Fmoc-protected amino functionality and a free α-carboxyl group, and it bears an allyl ester on the side-chain carboxyl that can act as a temporary protecting group for the β-carboxylate during peptide assembly. In peptide chemistry and solid-phase peptide synthesis workflows, this structure supports stepwise coupling of the α-carboxyl/α-amino components while the allyl ester and Fmoc group help control chemoselectivity for side-chain modification and downstream deprotection strategies.
CAT No: CP00421
CAS No:146982-24-3
Synonyms/Alias:Fmoc-Asp(OAll)-OH;146982-24-3;Fmoc-L-asparticacid4-allylester;Fmoc-Asp(Oallyl)-OH;AmbotzFAA1353;Fmoc-Asp(OAl)-OH;PubChem12449;47579_ALDRICH;SCHEMBL8037759;47579_FLUKA;CTK8C6841;MolPort-003-934-193;262429-39-0;ZINC2556580;MFCD00190874;AKOS015839098;AKOS015908600;CS13727;RTR-005848;AJ-39934;AK-49405;AB0069099;TR-005848;FT-0659763;ST24030713
Fmoc-L-aspartic acid β-allyl ester is an Fmoc-protected L-aspartate derivative in which the side-chain carboxyl group is converted to a β-allyl ester, while the α-amino functionality is masked as the fluorenylmethoxycarbonyl (Fmoc) carbamate. The molecule therefore presents a stereodefined chiral α-center typical of L-aspartate, a protected carboxylate equivalent suitable for controlled deprotection chemistry, and an allyl ester handle for orthogonal transformations. The allyl ester can undergo selective deprotection or functional group conversion under conditions compatible with peptide synthesis, whereas the Fmoc group supports base-labile N-deprotection to reveal the amino nucleophile for coupling. The combination of an orthogonally protected side-chain ester and an N-protecting group makes this compound a practical chiral intermediate for peptide building block preparation and downstream functionalization of aspartate-containing sequences.
1. Peptide Synthesis
Fmoc-L-aspartic acid β-allyl ester is used in peptide coupling workflows where orthogonal protection of the aspartate side chain is required to control chemoselectivity during chain assembly. The Fmoc carbamate enables standard N-terminal activation and stepwise elongation by providing a protected amino group that can be deprotected to regenerate the free amine for amide bond formation. The β-allyl ester functions as a side-chain carboxyl equivalent that can remain intact through multiple coupling cycles, supporting the construction of aspartate-rich peptides without premature side-chain interference. Subsequent allyl ester conversion can furnish the native side-chain carboxylate or a derivative suitable for post-assembly modification, aligning with peptide science requirements for clean deprotection sequences and reproducible functional group presentation.
2. Side-Chain Functionalization
Fmoc-L-aspartic acid β-allyl ester supports side-chain functionalization strategies in chemical synthesis and chemical biology by leveraging the allyl ester as an orthogonal reactive handle. The aspartate β-allyl ester can be transformed into alternative carboxyl-derived motifs or used to generate reactive carboxylate functionality after selective deprotection, enabling controlled installation of acidic groups or carboxylate-based ligation sites. The retained stereochemistry at the α-center helps maintain the L-aspartate configuration in derived peptides and conjugates, which can be relevant for molecular recognition and structure-activity relationship studies. Downstream conversion of the side-chain functionality enables access to aspartate analogs used in fragment elaboration, scaffold diversification, and functional group mapping for biomolecular interaction research.
3. Bioconjugation Chemistry
Fmoc-L-aspartic acid β-allyl ester is applicable to bioconjugation and biomolecule modification workflows where carboxylate-bearing amino acid residues are needed for controlled attachment chemistries. The compound's Fmoc-protected amine can be incorporated into peptide or peptidomimetic linkers, while the β-allyl ester provides a protected acidic group that can be revealed or converted to a carboxylate under orthogonal conditions. The resulting aspartate side-chain functionality can participate in coupling reactions, linker installation, or further derivatization to generate conjugates with defined charge distribution and spacing. Use of this chiral amino acid derivative in linker synthesis supports downstream generation of peptide-based tags, affinity reagents, and chemically defined bioconjugation intermediates for analytical and research applications.
4. Peptidomimetics And SAR Studies
Fmoc-L-aspartic acid β-allyl ester is suitable for peptidomimetic construction and structure-activity relationship studies that require aspartate-like stereochemistry and a programmable side-chain carboxylate. The Fmoc group enables incorporation into protected peptide fragments, while the β-allyl ester allows side-chain manipulation after assembly to generate either the native acidic functionality or alternative carboxyl-derived substituents. The stereodefined L-aspartate backbone supports consistent spatial orientation of the side-chain, which can be important when comparing analog series in SAR investigations. Conversion of the allyl ester after fragment elaboration can produce a set of structurally related analogs for binding studies, receptor modulation mapping, and mechanistic probing in chemical biology research.
5. Process Chemistry Intermediate
Fmoc-L-aspartic acid β-allyl ester serves as a chiral intermediate for process chemistry and fine chemical synthesis where orthogonally protected amino acid derivatives streamline manufacturing of protected peptide building blocks. The Fmoc carbamate provides a robust N-protection strategy compatible with iterative coupling and purification operations, while the β-allyl ester offers a side-chain protection mode that can be selectively transformed to the corresponding acid functionality in downstream steps. The presence of an allyl group supports conversion routes that can be integrated into scalable synthetic sequences for producing aspartate-containing intermediates and peptide fragments. Industrial utilization is enabled by the compound's clear functional group partitioning between base-labile N-deprotection and orthogonal side-chain ester conversion, supporting reproducible intermediate generation for specialty chemical production and pharmaceutical intermediate preparation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.